Premium
Prevalence of vitiligo among type 2 diabetic patients in an Iranian population
Author(s) -
AfkhamiArdekani Mohammad,
GhadiriAnari Akram,
EbrahimzadehArdakani Mohammad,
Zaji Neda
Publication year - 2014
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/ijd.12148
Subject(s) - vitiligo , medicine , diabetes mellitus , incidence (geometry) , population , dermatology , significant difference , type 2 diabetes , endocrinology , physics , environmental health , optics
Background Vitiligo is one of many diseases that can be found with diabetes mellitus. Diabetic patients have a high incidence of vitiligo compared to the general population. This study assesses prevalence of vitiligo in type 2 diabetic patients in I ran. Methods One thousand one hundred type 2 diabetic patients and 1100 healthy adults were recruited in this cross‐sectional study. Patients were evaluated for vitiligo by a dermatologist both clinically and by Wood's lamp. Data were analyzed using SPSS . P value ≤0.05 was considered statistically significant. Results There was a significant difference between groups with respect to presence of vitiligo; 4.9% of diabetic patients had vitiligo versus 1.8% of control group ( P = 0.001). In the female group with diabetes, 5.8% had vitiligo, and in male diabetic patients, 3.9% had vitiligo ( P = 0.057). In the control group, 1.8% of females and 1.8% of males had vitiligo that was equal. Conclusion Vitiligo and diabetes may have a causal relationship. Vitiligo may coexist with type 2 diabetes. Therefore it is reasonable to investigate each patient periodically.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom